论文部分内容阅读
国产瑞格列奈治疗伴或不伴肾功能不全的2型糖尿病患者12周后能有效降低空腹血糖、餐后血糖和糖化血红蛋白(P<0.01),且治疗前后肝肾功能无明显变化。
Domestic repaglinide treatment of type 2 diabetic patients with or without renal insufficiency can reduce fasting blood glucose, postprandial blood glucose and glycosylated hemoglobin (P <0.01) 12 weeks after treatment, and no significant changes in liver and kidney function before and after treatment.